Paritosh Dey is currently a Researcher at IOCB Prague, involved in advanced research at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences since November 2023. Previously, Paritosh worked as a Master Thesis Student at the National Institute of Technology Calicut, focusing on the synthesis and characterization of benzimidazole-fused thiophene hybrids and their biological evaluations from October 2022 to May 2023, under the guidance of Dr. Janardhan Banothu. Additionally, a summer internship was completed at the Institute of Chemical Technology in mid-2022, where Paritosh synthesized and characterized specific chemical compounds under Dr. Nabanita Sadhukhan's supervision. Paritosh Dey holds a Master of Science in Chemistry from the National Institute of Technology Calicut (2021-2023) and a Bachelor of Science in Chemistry from Adamas University (2018-2021), and is currently pursuing a PhD in Organic Chemistry at Charles University.

Location

Prague, Czech Republic

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences

1 followers

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.


Employees

501-1,000

Links